Philippe Dussart Selected Research

Philippe Dussart Research Topics

Disease

31	Infections 06/2023 - 06/2005
24	Dengue (Dengue Fever) 05/2024 - 11/2005
4	Severe Dengue 05/2024 - 01/2020
3	Rabies (Hydrophobia) 04/2024 - 12/2019
2	Human Influenza (Influenza) 01/2023 - 01/2019
2	COVID-19 12/2022 - 06/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 08/2017
2	Bites and Stings (Sting) 10/2019 - 01/2018
1	Scrub Typhus (Typhus, Scrub) 12/2023
1	Epidemic Louse-Borne Typhus (Typhus) 12/2023
1	Disease Progression 06/2023
1	Tuberculosis (Tuberculoses) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Asymptomatic Infections 01/2022
1	Convalescence 01/2022
1	Zoonoses 01/2022
1	Coma (Comas) 01/2022
1	Disease Susceptibility (Diathesis) 01/2021
1	Coinfection 12/2020
1	Tick Bites 11/2019
1	Encephalitis (Encephalitis, Rasmussen) 10/2019
1	Meningoencephalitis 05/2017
1	Proteinuria 02/2017
1	Malaria 01/2013

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 12/2023 - 06/2005
9	AntibodiesIBA 01/2023 - 02/2012
8	VaccinesIBA 05/2024 - 02/2012
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
7	EnzymesIBA 12/2023 - 11/2005
7	AntigensIBA 01/2022 - 11/2005
6	ImmunosorbentsIBA 12/2023 - 11/2005
6	Immunoglobulin M (IgM)IBA 01/2023 - 11/2006
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2012
4	Neutralizing AntibodiesIBA 04/2024 - 01/2022
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2019
2	Interleukin-10 (Interleukin 10)IBA 05/2024 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2019
1	Lipopolysaccharide ReceptorsIBA 06/2023
1	AerosolsIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	Blocking AntibodiesIBA 10/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2021
1	AutoantigensIBA 12/2020
1	Surface Antigens (Surface Antigen)IBA 12/2020
1	Complement System Proteins (Complement)IBA 12/2020
1	AutoantibodiesIBA 12/2020
1	Indicators and Reagents (Reagents)IBA 09/2020
1	Interferon Type IIBA 01/2020
1	phosphatidylserine receptorIBA 01/2020
1	LuciferasesIBA 11/2019
1	Japanese Encephalitis VaccinesIBA 10/2019
1	Zanamivir (Relenza)FDA Link 01/2019
1	CytokinesIBA 01/2019
1	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2019
1	anti-IgMIBA 01/2019
1	Oseltamivir (Tamiflu)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	methylamphotericin B (AME)IBA 05/2017
1	CreatinineIBA 02/2017
1	Immunoglobulin A (IgA)IBA 05/2016
1	C-Reactive ProteinIBA 01/2013
1	EpitopesIBA 02/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2012

Therapy/Procedure

2	Blood Transfusion (Blood Transfusions) 06/2021 - 01/2019
1	Intradermal Injections 12/2019